Descrizione del progetto
Aprire le porte alla medicina personalizzata per la demenza
La medicina personalizzata tiene conto della variabilità individuale e delle caratteristiche uniche, come il patrimonio genetico, i biomarcatori e i dati sanitari personali, per fornire trattamenti e strategie preventive su misura. Sebbene la medicina personalizzata abbia un grande potenziale, la mancanza di strumenti adeguati ne ha impedito l’attuazione. Finanziato dal programma HORIZON, il progetto PROMINENT intende sviluppare una piattaforma digitale per la medicina di precisione, affrontando le barriere nell’utilizzo di diagnostica avanzata e terapie modificanti la malattia. La piattaforma comprenderà modelli di previsione che si basano su varie fonti di dati diagnostici e si concentrerà sui disturbi neurodegenerativi, la cui prevalenza è in aumento a causa dell’invecchiamento della popolazione. I risultati attesi comprendono una maggiore precisione diagnostica, una migliore applicazione di nuove opzioni terapeutiche e un miglioramento dei risultati sanitari.
Obiettivo
Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually. Comorbidities with these conditions are frequent and a major obstacle to optimal diagnosis and management. Recent advances in diagnostic technologies and the advent of disease-modifying therapies (DMT) for Alzheimer’s disease (AD), the most common aetiology of dementia, heralds the beginning of precision medicine in this disease area. PROMINENT will develop a digital platform for precision medicine that will remove barriers that currently exists for leveraging these technological advancements in the routine care of patients with neurodegenerative disorders and co-morbidities. The platform gives clinicians access to prediction models leveraging multimodal diagnostic data automatically derived from multiple sources (imaging repositories, medical records, mobile devices), helping them choose optimal care pathways and improving diagnostic precision. It will provide personalized, relevant and meaningful information on diagnosis and prognosis in a format understandable by patients and care partners. Further, it will support the introduction of new health technologies such as DMT for AD, by ensuring adherence to appropriate use guidelines and facilitating the prospective collection of data on real-world usage, safety and effectiveness. The expected impact of the project is to increase diagnostic accuracy and optimized use of existing and new treatment options. It will empower patients and caregivers by engaging them in more person-centric health care decisions, leading to improved adherence and patient experience. Ultimately this is expected to lead to cost-effective care, improved health outcomes and quality of life.
Campo scientifico
Parole chiave
Programma(i)
- HORIZON.2.1 - Health Main Programme
- HORIZON.2.1.7 - Innovative Health Initiative
Invito a presentare proposte
HORIZON-JU-IHI-2022-01-single-stage
Vedi altri progetti per questo bandoMeccanismo di finanziamento
HORIZON-JU-RIA - HORIZON JU Research and Innovation ActionsCoordinatore
17177 Stockholm
Svezia